Hard-bitten vs. cold-hearted

Now that the biotech sector has had a long, cold reality shower, we suspect the hardy band of five companies trying to nudge open the public offerings window is doing so knowing full well what kind of prices to expect.

"The environment isn't particularly friendly and it may stay unfriendly for some

Read the full 520 word article

How to gain access

Continue reading with a
two-week free trial.